{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:16:03Z","timestamp":1779297363332,"version":"3.51.4"},"publisher-location":"Cham","reference-count":80,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783031169960","type":"print"},{"value":"9783031169977","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/7854_2022_372","type":"book-chapter","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T08:03:00Z","timestamp":1655280180000},"page":"169-191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Therapeutic Potential of Histamine H3 Receptors in Substance Use Disorders"],"prefix":"10.1007","author":[{"given":"Patricia","family":"Di Ciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian S.","family":"Hendershot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Le Foll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,16]]},"reference":[{"key":"372_CR1","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.bbr.2012.09.025","volume":"237","author":"L Alleva","year":"2013","unstructured":"Alleva L, Tirelli E, Brabant C (2013) Therapeutic potential of histaminergic compounds in the treatment of addiction and drug-related cognitive disorders. Behav Brain Res 237:357\u2013368. https:\/\/doi.org\/10.1016\/j.bbr.2012.09.025","journal-title":"Behav Brain Res"},{"issue":"1","key":"372_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/sj.bjp.0704053","volume":"133","author":"JA Arias-Montano","year":"2001","unstructured":"Arias-Montano JA, Floran B, Garcia M, Aceves J, Young JM (2001) Histamine H(3) receptor-mediated inhibition of depolarization-induced, dopamine D(1) receptor-dependent release of [(3)H]-gamma-aminobutyric acid from rat striatal slices. Br J Pharmacol 133(1):165\u2013171. https:\/\/doi.org\/10.1038\/sj.bjp.0704053","journal-title":"Br J Pharmacol"},{"issue":"5911","key":"372_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/302832a0","volume":"302","author":"JM Arrang","year":"1983","unstructured":"Arrang JM, Garbarg M, Schwartz JC (1983) Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature 302(5911):832\u2013837. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6188956","journal-title":"Nature"},{"issue":"1","key":"372_CR4","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00213-013-3019-7","volume":"228","author":"A Bahi","year":"2013","unstructured":"Bahi A, Sadek B, Schwed SJ, Walter M, Stark H (2013) Influence of the novel histamine H(3) receptor antagonist ST1283 on voluntary alcohol consumption and ethanol-induced place preference in mice. Psychopharmacology (Berl) 228(1):85\u201395. https:\/\/doi.org\/10.1007\/s00213-013-3019-7","journal-title":"Psychopharmacology (Berl)"},{"key":"372_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.physbeh.2015.07.012","volume":"151","author":"A Bahi","year":"2015","unstructured":"Bahi A, Sadek B, Nurulain SM, Lazewska D, Kiec-Kononowicz K (2015) The novel non-imidazole histamine H3 receptor antagonist DL77 reduces voluntary alcohol intake and ethanol-induced conditioned place preference in mice. Physiol Behav 151:189\u2013197. https:\/\/doi.org\/10.1016\/j.physbeh.2015.07.012","journal-title":"Physiol Behav"},{"issue":"3","key":"372_CR6","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1159\/000191473","volume":"83","author":"ML Banks","year":"2009","unstructured":"Banks ML, Manvich DF, Bauzo RM, Howell LL (2009) Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys. Pharmacology 83(3):164\u2013169. https:\/\/doi.org\/10.1159\/000191473","journal-title":"Pharmacology"},{"issue":"5","key":"372_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/sj.bjp.0705964","volume":"143","author":"AJ Barbier","year":"2004","unstructured":"Barbier AJ, Berridge C, Dugovic C, Laposky AD, Wilson SJ, Boggs J et al (2004) Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist. Br J Pharmacol 143(5):649\u2013661. https:\/\/doi.org\/10.1038\/sj.bjp.0705964","journal-title":"Br J Pharmacol"},{"issue":"Suppl 1","key":"372_CR8","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1007\/BF03354086","volume":"45","author":"P Blandina","year":"1996","unstructured":"Blandina P, Giorgetti M, Cecchi M, Leurs R, Timmerman H, Giovannini MG (1996) Histamine H3 receptor inhibition of K(+)-evoked release of acetylcholine from rat cortex in vivo. Inflamm Res 45(Suppl 1):S54\u2013S55. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8696930","journal-title":"Inflamm Res"},{"issue":"8","key":"372_CR9","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2006.10.031","volume":"73","author":"P Bonaventure","year":"2007","unstructured":"Bonaventure P, Letavic M, Dugovic C, Wilson S, Aluisio L, Pudiak C et al (2007) Histamine H3 receptor antagonists: from target identification to drug leads. Biochem Pharmacol 73(8):1084\u20131096. https:\/\/doi.org\/10.1016\/j.bcp.2006.10.031","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"372_CR10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.bbr.2004.11.029","volume":"160","author":"C Brabant","year":"2005","unstructured":"Brabant C, Charlier Y, Quertemont E, Tirelli E (2005) The H3 antagonist thioperamide reveals conditioned preference for a context associated with an inactive small dose of cocaine in C57BL\/6J mice. Behav Brain Res 160(1):161\u2013168. https:\/\/doi.org\/10.1016\/j.bbr.2004.11.029","journal-title":"Behav Brain Res"},{"issue":"4","key":"372_CR11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.pbb.2006.03.018","volume":"83","author":"C Brabant","year":"2006","unstructured":"Brabant C, Quertemont E, Tirelli E (2006) Effects of the H3-receptor inverse agonist thioperamide on the psychomotor effects induced by acutely and repeatedly given cocaine in C57BL\/6J mice. Pharmacol Biochem Behav 83(4):561\u2013569. https:\/\/doi.org\/10.1016\/j.pbb.2006.03.018","journal-title":"Pharmacol Biochem Behav"},{"issue":"4","key":"372_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00213-008-1345-y","volume":"202","author":"C Brabant","year":"2009","unstructured":"Brabant C, Alleva L, Grisar T, Quertemont E, Lakaye B, Ohtsu H et al (2009) Effects of the H3 receptor inverse agonist thioperamide on cocaine-induced locomotion in mice: role of the histaminergic system and potential pharmacokinetic interactions. Psychopharmacology (Berl) 202(4):673\u2013687. https:\/\/doi.org\/10.1007\/s00213-008-1345-y","journal-title":"Psychopharmacology (Berl)"},{"key":"372_CR13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbr.2012.12.063","volume":"243","author":"C Brabant","year":"2013","unstructured":"Brabant C, Charlier Y, Tirelli E (2013) The histamine H(3)-receptor inverse agonist pitolisant improves fear memory in mice. Behav Brain Res 243:199\u2013204. https:\/\/doi.org\/10.1016\/j.bbr.2012.12.063","journal-title":"Behav Brain Res"},{"key":"372_CR14","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.ejphar.2016.08.027","volume":"791","author":"C Brabant","year":"2016","unstructured":"Brabant C, Charlier Y, Navacerrada MES, Alleva L, Tirelli E (2016) Action of pitolisant on the stimulant and rewarding effects of cocaine in mice. Eur J Pharmacol 791:552\u2013559. https:\/\/doi.org\/10.1016\/j.ejphar.2016.08.027","journal-title":"Eur J Pharmacol"},{"key":"372_CR15","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2147\/NSS.S103462","volume":"9","author":"MW Calik","year":"2017","unstructured":"Calik MW (2017) Update on the treatment of narcolepsy: clinical efficacy of pitolisant. Nat Sci Sleep 9:127\u2013133. https:\/\/doi.org\/10.2147\/NSS.S103462","journal-title":"Nat Sci Sleep"},{"issue":"2","key":"372_CR16","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1124\/jpet.105.090829","volume":"315","author":"VC Campbell","year":"2005","unstructured":"Campbell VC, Kopajtic TA, Newman AH, Katz JL (2005) Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. J Pharmacol Exp Ther 315(2):631\u2013640. https:\/\/doi.org\/10.1124\/jpet.105.090829","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"372_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/0014-2999(94)90498-7","volume":"259","author":"J Clapham","year":"1994","unstructured":"Clapham J, Kilpatrick GJ (1994) Thioperamide, the selective histamine H3 receptor antagonist, attenuates stimulant-induced locomotor activity in the mouse. Eur J Pharmacol 259(2):107\u2013114. https:\/\/doi.org\/10.1016\/0014-2999(94)90498-7","journal-title":"Eur J Pharmacol"},{"issue":"8","key":"372_CR18","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1016\/j.bcp.2007.02.010","volume":"73","author":"M Cowart","year":"2007","unstructured":"Cowart M, Gfesser GA, Browman KE, Faghih R, Miller TR, Milicic I et al (2007) Novel heterocyclic-substituted benzofuran histamine H3 receptor antagonists: in vitro properties, drug-likeness, and behavioral activity. Biochem Pharmacol 73(8):1243\u20131255. https:\/\/doi.org\/10.1016\/j.bcp.2007.02.010","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"372_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/14656566.2020.1817387","volume":"22","author":"S de Biase","year":"2021","unstructured":"de Biase S, Pellitteri G, Gigli GL, Valente M (2021) Evaluating pitolisant as a narcolepsy treatment option. Expert Opin Pharmacother 22(2):155\u2013162. https:\/\/doi.org\/10.1080\/14656566.2020.1817387","journal-title":"Expert Opin Pharmacother"},{"issue":"2","key":"372_CR20","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/BF00432175","volume":"75","author":"H de Wit","year":"1981","unstructured":"de Wit H, Stewart J (1981) Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology (Berl) 75(2):134\u2013143. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6798603","journal-title":"Psychopharmacology (Berl)"},{"key":"372_CR21","first-page":"367","volume-title":"The mesolimbic dopamine system: from motivation to action. Role of mesolimbic dopamine in the motivational effects of drugs: Brain dialysis and place preference studies","author":"G Di Chiara","year":"1991","unstructured":"Di Chiara G, Acquas E, Carboni E (1991) The mesolimbic dopamine system: from motivation to action. Role of mesolimbic dopamine in the motivational effects of drugs: Brain dialysis and place preference studies. In: Willner P, Scheel-Kruger J (eds) . Wiley, pp 367\u2013384"},{"issue":"1\u20132","key":"372_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00213-003-1470-6","volume":"168","author":"DH Epstein","year":"2003","unstructured":"Epstein DH, Preston KL (2003) The reinstatement model and relapse prevention: a clinical perspective. Psychopharmacology (Berl) 168(1\u20132):31\u201341. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12721778","journal-title":"Psychopharmacology (Berl)"},{"issue":"3816","key":"372_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1126\/science.159.3816.739","volume":"159","author":"K Eriksson","year":"1968","unstructured":"Eriksson K (1968) Genetic selection for voluntary alcohol consumption in the albino rat. Science 159(3816):739\u2013741. https:\/\/doi.org\/10.1126\/science.159.3816.739","journal-title":"Science"},{"issue":"2","key":"372_CR24","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neuropharm.2008.05.008","volume":"55","author":"C Ferrada","year":"2008","unstructured":"Ferrada C, Ferre S, Casado V, Cortes A, Justinova Z, Barnes C, Canela EI, Goldberg SR, Leurs R, Lluis C, Franco R (2008) Interactions between histamine H3 and dopamine D2 receptors and the implications for striatal function. Neuropharmacology 55(2):190\u2013197. https:\/\/doi.org\/10.1016\/j.neuropharm.2008.05.008","journal-title":"Neuropharmacology"},{"issue":"1","key":"372_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1124\/jpet.104.078402","volume":"313","author":"GB Fox","year":"2005","unstructured":"Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA (2005) Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist. J Pharmacol Exp Ther 313(1):176\u2013190. https:\/\/doi.org\/10.1124\/jpet.104.078402","journal-title":"J Pharmacol Exp Ther"},{"issue":"8","key":"372_CR26","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.neuropharm.2009.03.011","volume":"56","author":"R Galici","year":"2009","unstructured":"Galici R, Boggs JD, Aluisio L, Fraser IC, Bonaventure P, Lord B, Lovenberg TW (2009) JNJ-10181457, a selective non-imidazole histamine H(3) receptor antagonist, normalizes acetylcholine neurotransmission and has efficacy in translational rat models of cognition. Neuropharmacology 56(8):1131\u20131137. https:\/\/doi.org\/10.1016\/j.neuropharm.2009.03.011","journal-title":"Neuropharmacology"},{"issue":"4","key":"372_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00213-010-2092-4","volume":"214","author":"R Galici","year":"2011","unstructured":"Galici R, Rezvani AH, Aluisio L, Lord B, Levin ED, Fraser I, Boggs J, Welty N, Shoblock JR, Motley ST, Letavic MA, Carruthers NI, Dugovic C, Lovenberg TW, Bonaventure P (2011) JNJ-39220675, a novel selective histamine H3 receptor antagonist, reduces the abuse-related effects of alcohol in rats. Psychopharmacology (Berl) 214(4):829\u2013841. https:\/\/doi.org\/10.1007\/s00213-010-2092-4","journal-title":"Psychopharmacology (Berl)"},{"issue":"2","key":"372_CR28","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bbr.2004.03.007","volume":"154","author":"M Garcia-Ramirez","year":"2004","unstructured":"Garcia-Ramirez M, Aceves J, Arias-Montano JA (2004) Intranigral injection of the H3 agonist immepip and systemic apomorphine elicit ipsilateral turning behaviour in naive rats, but reduce contralateral turning in hemiparkinsonian rats. Behav Brain Res 154(2):409\u2013415. https:\/\/doi.org\/10.1016\/j.bbr.2004.03.007","journal-title":"Behav Brain Res"},{"issue":"2","key":"372_CR29","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.bbr.2012.04.033","volume":"232","author":"G Griebel","year":"2012","unstructured":"Griebel G, Decobert M, Jacquet A, Beeske S (2012) Awakening properties of newly discovered highly selective H(3) receptor antagonists in rats. Behav Brain Res 232(2):416\u2013420. https:\/\/doi.org\/10.1016\/j.bbr.2012.04.033","journal-title":"Behav Brain Res"},{"issue":"1\u20133","key":"372_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ejphar.2004.01.015","volume":"487","author":"AA Hancock","year":"2004","unstructured":"Hancock AA, Bennani YL, Bush EN, Esbenshade TA, Faghih R, Fox GB, Jacobson P, Knourek-Segel V, Krueger KM, Nuss ME, Pan JB, Shapiro R, Witte DG, Yao BB (2004) Antiobesity effects of A-331440, a novel non-imidazole histamine H3 receptor antagonist. Eur J Pharmacol 487(1\u20133):183\u2013197. https:\/\/doi.org\/10.1016\/j.ejphar.2004.01.015","journal-title":"Eur J Pharmacol"},{"key":"372_CR31","doi-asserted-by":"publisher","unstructured":"Harwell V, Fasinu PS (2020) Pitolisant and other histamine-3 receptor antagonists-an update on therapeutic potentials and clinical prospects. Medicines (Basel) 7(9). https:\/\/doi.org\/10.3390\/medicines7090055","DOI":"10.3390\/medicines7090055"},{"key":"372_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.pharmthera.2017.02.039","volume":"175","author":"W Hu","year":"2017","unstructured":"Hu W, Chen Z (2017) The roles of histamine and its receptor ligands in central nervous system disorders: An update. Pharmacol Ther 175:116\u2013132. https:\/\/doi.org\/10.1016\/j.pharmthera.2017.02.039","journal-title":"Pharmacol Ther"},{"key":"372_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2019.02.019","volume":"851","author":"B Huyts","year":"2019","unstructured":"Huyts B, Brabant C, Tirelli E (2019) Pitolisant and intravenous cocaine self-administration in mice. Eur J Pharmacol 851:63\u201368. https:\/\/doi.org\/10.1016\/j.ejphar.2019.02.019","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"372_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.schres.2015.01.041","volume":"164","author":"LF Jarskog","year":"2015","unstructured":"Jarskog LF, Lowy MT, Grove RA, Keefe RS, Horrigan JP, Ball MP, Breier A, Buchanan RW, Carter CS, Csernansky JG, Goff DC, Green MF, Kantrowitz JT, Keshavan MS, Laurelle M, Lieberman JA, Marder SR, Maruff P, McMahon RP, Seidman LJ, Peykamian MA (2015) A Phase II study of a histamine H(3) receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy. Schizophr Res 164(1\u20133):136\u2013142. https:\/\/doi.org\/10.1016\/j.schres.2015.01.041","journal-title":"Schizophr Res"},{"issue":"1\u20132","key":"372_CR35","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2007.04.051","volume":"569","author":"E Kholdebarin","year":"2007","unstructured":"Kholdebarin E, Caldwell DP, Blackwelder WP, Kao M, Christopher NC, Levin ED (2007) Interaction of nicotinic and histamine H(3) systems in the radial-arm maze repeated acquisition task. Eur J Pharmacol 569(1\u20132):64\u201369. https:\/\/doi.org\/10.1016\/j.ejphar.2007.04.051","journal-title":"Eur J Pharmacol"},{"key":"372_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-3-0348-7,309-3_4","volume":"33","author":"GJ Kilpatrick","year":"1991","unstructured":"Kilpatrick GJ, Michel AD (1991) Characterisation of the binding of the histamine H3 receptor agonist [3H] (R)-alpha methyl histamine to homogenates of rat and guinea-pig cortex. Agents Actions Suppl 33:69\u201375. https:\/\/doi.org\/10.1007\/978-3-0348-7,309-3_4","journal-title":"Agents Actions Suppl"},{"key":"372_CR37","doi-asserted-by":"publisher","first-page":"146873","DOI":"10.1016\/j.brainres.2020.146873","volume":"1740","author":"J Kitanaka","year":"2020","unstructured":"Kitanaka J, Kitanaka N, Hall FS, Amatsu Y, Hashimoto K, Hisatomi E, Kitao E, Mimura M, Nakamura M, Ozawa R, Sato M, Tagami K, Uhl GR, Takemura M (2020) In vivo evaluation of effects of histamine H3 receptor antagonists on methamphetamine-induced hyperlocomotion in mice. Brain Res 1740:146873. https:\/\/doi.org\/10.1016\/j.brainres.2020.146873","journal-title":"Brain Res"},{"issue":"4","key":"372_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s00213-003-1431-0","volume":"167","author":"VA Komater","year":"2003","unstructured":"Komater VA, Browman KE, Curzon P, Hancock AA, Decker MW, Fox GB (2003) H3 receptor blockade by thioperamide enhances cognition in rats without inducing locomotor sensitization. Psychopharmacology (Berl) 167(4):363\u2013372. https:\/\/doi.org\/10.1007\/s00213-003-1431-0","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"372_CR39","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1016\/s1734-1140(12)70929-5","volume":"64","author":"M Kruk","year":"2012","unstructured":"Kruk M, Miszkiel J, McCreary AC, Przegalinski E, Filip M, Biala G (2012) Effects of the histamine H(3) receptor antagonist ABT-239 on cognition and nicotine-induced memory enhancement in mice. Pharmacol Rep 64(6):1316\u20131325. https:\/\/doi.org\/10.1016\/s1734-1140(12)70929-5","journal-title":"Pharmacol Rep"},{"issue":"3","key":"372_CR40","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3233\/JAD-150393","volume":"48","author":"M Kubo","year":"2015","unstructured":"Kubo M, Kishi T, Matsunaga S, Iwata N (2015) Histamine H3 receptor antagonists for Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized placebo-controlled trials. J Alzheimers Dis 48(3):667\u2013671. https:\/\/doi.org\/10.3233\/JAD-150393","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"372_CR41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s40263-020-00703-x","volume":"34","author":"YN Lamb","year":"2020","unstructured":"Lamb YN (2020) Pitolisant: a review in narcolepsy with or without cataplexy. CNS Drugs 34(2):207\u2013218. https:\/\/doi.org\/10.1007\/s40263-020-00703-x","journal-title":"CNS Drugs"},{"issue":"9","key":"372_CR42","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1517\/13543776.2010.509346","volume":"20","author":"D Lazewska","year":"2010","unstructured":"Lazewska D, Kiec-Kononowicz K (2010) Recent advances in histamine H3 receptor antagonists\/inverse agonists. Expert Opin Ther Pat 20(9):1147\u20131169. https:\/\/doi.org\/10.1517\/13543776.2010.509346","journal-title":"Expert Opin Ther Pat"},{"key":"372_CR43","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1126\/science.278.5335.45","volume":"278","author":"AI Leshner","year":"1997","unstructured":"Leshner AI (1997) Addiction is a brain disease, and it matters. Science 278:45\u201347","journal-title":"Science"},{"issue":"14","key":"372_CR44","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1016\/j.bmcl.2010.05.041","volume":"20","author":"MA Letavic","year":"2010","unstructured":"Letavic MA, Aluisio L, Atack JR, Bonaventure P, Carruthers NI, Dugovic C, Everson A, Feinstein MA, Fraser IC, Hoey K, Jiang X, Keith JM, Koudriakova T, Leung P, Lord B, Lovenberg TW, Ly KS, Morton KL, Timothy Motley S, Nepomuceno D, Rizzolio M, Rynberg R, Sepassi K, Shelton J (2010) Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical development. Bioorg Med Chem Lett 20(14):4210\u20134214. https:\/\/doi.org\/10.1016\/j.bmcl.2010.05.041","journal-title":"Bioorg Med Chem Lett"},{"issue":"8","key":"372_CR45","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.bcp.2007.01.023","volume":"73","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, Robert P, Parmentier R, Anaclet C, Lin J-S, Burban A, Arrang J-M, Schwartz JC (2007a) Brain histamine and schizophrenia: potential therapeutic applications of H3-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73(8):1215\u20131224. https:\/\/doi.org\/10.1016\/j.bcp.2007.01.023","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"372_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1124\/jpet.106.111039","volume":"320","author":"X Ligneau","year":"2007","unstructured":"Ligneau X, Perrin D, Landais L, Camelin JC, Calmels TP, Berrebi-Bertrand I, Lecomte J-M, Parmentier R, Anaclet C, Lin J-S, Bertaina-Anglade V, la Rochelle CD, d'Aniello F, Rouleau A, Gbahou F, Arrang J-M, Ganellin CR, Stark H, Schunack W, Schwartz JC (2007b) BF2.649 [1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine, hydrochloride], a nonimidazole inverse agonist\/antagonist at the human histamine H3 receptor: preclinical pharmacology. J Pharmacol Exp Ther 320(1):365\u2013375. https:\/\/doi.org\/10.1124\/jpet.106.111039","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"372_CR47","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/0006-8993(90)91508-E","volume":"523","author":"JS Lin","year":"1990","unstructured":"Lin JS, Sakai K, Vanni-Mercier G, Arrang JM, Garbarg M, Schwartz JC, Jouvet M (1990) Involvement of histaminergic neurons in arousal mechanisms demonstrated with H3-receptor ligands in the cat. Brain Res 523(2):325\u2013330. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2169324","journal-title":"Brain Res"},{"issue":"6","key":"372_CR48","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1096\/fj.00-0545fje","volume":"15","author":"M Lintunen","year":"2001","unstructured":"Lintunen M, Hyytia P, Sallmen T, Karlstedt K, Tuomisto L, Leurs R, Kiianmaa K, Korpi ER, Panula P (2001) Increased brain histamine in an alcohol-preferring rat line and modulation of ethanol consumption by H(3) receptor mechanisms. FASEB J 15(6):1074\u20131076. https:\/\/doi.org\/10.1096\/fj.00-0545fje","journal-title":"FASEB J"},{"issue":"2","key":"372_CR49","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0006-8993(90)91240-h","volume":"526","author":"MI Martinez-Mir","year":"1990","unstructured":"Martinez-Mir MI, Pollard H, Moreau J, Arrang JM, Ruat M, Traiffort E, Schwartz JC, Palacios JM (1990) Three histamine receptors (H1, H2 and H3) visualized in the brain of human and non-human primates. Brain Res 526(2):322\u2013327. https:\/\/doi.org\/10.1016\/0006-8993(90)91240-h","journal-title":"Brain Res"},{"issue":"3","key":"372_CR50","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1124\/jpet.107.120311","volume":"321","author":"AD Medhurst","year":"2007","unstructured":"Medhurst AD, Atkins AR, Beresford IJ, Brackenborough K, Briggs MA, Calver AR, Cilia J, Cluderay JE, Crook B, Davis JB, Davis RK, Davis RP, Dawson LA, Foley AG, Gartlon J, Gonzalez MI, Heslop T, Hirst WD, Jennings C, Jones DNC, Lacroix LP, Martyn A, Ociepka S, Ray A, Regan CM, Roberts JC, Schogger J, Southam E, Stean TO, Trail BK, Upton N, Wadsworth G, Wald JA, White T, Witherington J, Woolley ML, Worby A, Wilson DM (2007) GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer\u2019s disease brain and improves cognitive performance in preclinical models. J Pharmacol Exp Ther 321(3):1032\u20131045. https:\/\/doi.org\/10.1124\/jpet.107.120311","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"372_CR51","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/s1734-1,140(11)70720-4","volume":"63","author":"J Miszkiel","year":"2011","unstructured":"Miszkiel J, Kruk M, McCreary AC, Przegalinski E, Biala G, Filip M (2011) Effects of the histamine H3 receptor antagonist ABT-239 on acute and repeated nicotine locomotor responses in rats. Pharmacol Rep 63(6):1553\u20131559. https:\/\/doi.org\/10.1016\/s1734-1,140(11)70720-4","journal-title":"Pharmacol Rep"},{"key":"372_CR52","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.bbr.2016.02.025","volume":"305","author":"G Morais-Silva","year":"2016","unstructured":"Morais-Silva G, Ferreira-Santos M, Marin MT (2016) Conessine, an H3 receptor antagonist, alters behavioral and neurochemical effects of ethanol in mice. Behav Brain Res 305:100\u2013107. https:\/\/doi.org\/10.1016\/j.bbr.2016.02.025","journal-title":"Behav Brain Res"},{"issue":"7","key":"372_CR53","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1111\/j.1460-9568.2011.07618.x","volume":"33","author":"M Motawaj","year":"2011","unstructured":"Motawaj M, Arrang JM (2011) Ciproxifan, a histamine H(3)-receptor antagonist\/inverse agonist, modulates methamphetamine-induced sensitization in mice. Eur J Neurosci 33(7):1197\u20131204. https:\/\/doi.org\/10.1111\/j.1460-9568.2011.07618.x","journal-title":"Eur J Neurosci"},{"issue":"2\u20133","key":"372_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0014-2,999(98)00789-4","volume":"363","author":"P Munzar","year":"1998","unstructured":"Munzar P, Nosal R, Goldberg SR (1998) Potentiation of the discriminative-stimulus effects of methamphetamine by the histamine H3 receptor antagonist thioperamide in rats. Eur J Pharmacol 363(2\u20133):93\u2013101. https:\/\/doi.org\/10.1016\/s0014-2,999(98)00789-4","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"372_CR55","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/sj.npp.1300380","volume":"29","author":"P Munzar","year":"2004","unstructured":"Munzar P, Tanda G, Justinova Z, Goldberg SR (2004) Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29(4):705\u2013717. https:\/\/doi.org\/10.1038\/sj.npp.1300380","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"372_CR56","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00213-009-1710-5","volume":"208","author":"S Nuutinen","year":"2010","unstructured":"Nuutinen S, Karlstedt K, Aitta-Aho T, Korpi ER, Panula P (2010) Histamine and H3 receptor-dependent mechanisms regulate ethanol stimulation and conditioned place preference in mice. Psychopharmacology (Berl) 208(1):75\u201386. https:\/\/doi.org\/10.1007\/s00213-009-1710-5","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"372_CR57","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/npp.2011.90","volume":"36","author":"S Nuutinen","year":"2011","unstructured":"Nuutinen S, Lintunen M, Vanhanen J, Ojala T, Rozov S, Panula P (2011a) Evidence for the role of histamine H3 receptor in alcohol consumption and alcohol reward in mice. Neuropsychopharmacology 36(10):2030\u20132040. https:\/\/doi.org\/10.1038\/npp.2011.90","journal-title":"Neuropsychopharmacology"},{"issue":"7\u20138","key":"372_CR58","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.neuropharm.2010.10.027","volume":"60","author":"S Nuutinen","year":"2011","unstructured":"Nuutinen S, Vanhanen J, Pigni MC, Panula P (2011b) Effects of histamine H3 receptor ligands on the rewarding, stimulant and motor-impairing effects of ethanol in DBA\/2J mice. Neuropharmacology 60(7\u20138):1193\u20131199. https:\/\/doi.org\/10.1016\/j.neuropharm.2010.10.027","journal-title":"Neuropharmacology"},{"key":"372_CR59","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3389\/fnsys.2012.00036","volume":"6","author":"S Nuutinen","year":"2012","unstructured":"Nuutinen S, Vanhanen J, Maki T, Panula P (2012) Histamine h3 receptor: a novel therapeutic target in alcohol dependence? Front Syst Neurosci 6:36. https:\/\/doi.org\/10.3389\/fnsys.2012.00036","journal-title":"Front Syst Neurosci"},{"key":"372_CR60","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.neuropharm.2015.06.006","volume":"106","author":"S Nuutinen","year":"2016","unstructured":"Nuutinen S, Maki T, Rozov S, Backstrom P, Hyytia P, Piepponen P, Panula P (2016) Histamine H3 receptor antagonist decreases cue-induced alcohol reinstatement in mice. Neuropharmacology 106:156\u2013163. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.06.006","journal-title":"Neuropharmacology"},{"issue":"3","key":"372_CR61","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/bph.14634","volume":"177","author":"P Panula","year":"2020","unstructured":"Panula P (2020) Histamine, histamine H3 receptor, and alcohol use disorder. Br J Pharmacol 177(3):634\u2013641. https:\/\/doi.org\/10.1111\/bph.14634","journal-title":"Br J Pharmacol"},{"issue":"1","key":"372_CR62","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1124\/jpet.110.170928","volume":"336","author":"P Panula","year":"2011","unstructured":"Panula P, Nuutinen S (2011) Histamine and H3 receptor in alcohol-related behaviors. J Pharmacol Exp Ther 336(1):9\u201316. https:\/\/doi.org\/10.1124\/jpet.110.170928","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"372_CR63","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1124\/pr.114.010249","volume":"67","author":"P Panula","year":"2015","unstructured":"Panula P, Chazot PL, Cowart M, Gutzmer R, Leurs R, Liu WL, Stark H, Thurmond RL, Haas HL (2015) International union of basic and clinical pharmacology. XCVIII. Histamine receptors. Pharmacol Rev 67(3):601\u2013655. https:\/\/doi.org\/10.1124\/pr.114.010249","journal-title":"Pharmacol Rev"},{"issue":"1\u20133","key":"372_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00213-008-1171-2","volume":"202","author":"V Pascoli","year":"2009","unstructured":"Pascoli V, Boer-Saccomani C, Hermant JF (2009) H3 receptor antagonists reverse delay-dependent deficits in novel object discrimination by enhancing retrieval. Psychopharmacology (Berl) 202(1\u20133):141\u2013152. https:\/\/doi.org\/10.1007\/s00213-008-1171-2","journal-title":"Psychopharmacology (Berl)"},{"key":"372_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nlm.2017.08.007","volume":"145","author":"MB Passani","year":"2017","unstructured":"Passani MB, Benetti F, Blandina P, Furini CRG, de Carvalho Myskiw J, Izquierdo I (2017) Histamine regulates memory consolidation. Neurobiol Learn Mem 145:1\u20136. https:\/\/doi.org\/10.1016\/j.nlm.2017.08.007","journal-title":"Neurobiol Learn Mem"},{"key":"372_CR66","doi-asserted-by":"publisher","first-page":"112997","DOI":"10.1016\/j.bbr.2020.112997","volume":"399","author":"D Patel","year":"2021","unstructured":"Patel D, Vishwakarma PK, Patel R, Jain NS (2021) Central histaminergic transmission modulates the expression of chronic nicotine withdrawal induced anxiety-like and somatic behavior in mice. Behav Brain Res 399:112997. https:\/\/doi.org\/10.1016\/j.bbr.2020.112997","journal-title":"Behav Brain Res"},{"issue":"1","key":"372_CR67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-0270(95)00153-0","volume":"66","author":"NR Richardson","year":"1996","unstructured":"Richardson NR, Roberts DC (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J Neurosci Methods 66(1):1\u201311. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8794935","journal-title":"J Neurosci Methods"},{"issue":"15","key":"372_CR68","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1111\/bph.15067","volume":"177","author":"P Rusjan","year":"2020","unstructured":"Rusjan P, Sabioni P, Di Ciano P, Mansouri E, Boileau I, Laveille A, Capet M, Duvauchelle T, Schwartz J-C, Robert P, Le Foll B (2020) Exploring occupancy of the histamine H3 receptor by pitolisant in humans using PET. Br J Pharmacol 177(15):3464\u20133472. https:\/\/doi.org\/10.1111\/bph.15067","journal-title":"Br J Pharmacol"},{"key":"372_CR69","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.bbr.2016.06.051","volume":"312","author":"B Sadek","year":"2016","unstructured":"Sadek B, Saad A, Sadeq A, Jalal F, Stark H (2016) Histamine H3 receptor as a potential target for cognitive symptoms in neuropsychiatric diseases. Behav Brain Res 312:415\u2013430. https:\/\/doi.org\/10.1016\/j.bbr.2016.06.051","journal-title":"Behav Brain Res"},{"issue":"2","key":"372_CR70","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1111\/j.1472-8206.1994.tb00789.x","volume":"8","author":"E Schlicker","year":"1994","unstructured":"Schlicker E, Malinowska B, Kathmann M, Gothert M (1994) Modulation of neurotransmitter release via histamine H3 heteroreceptors. Fundam Clin Pharmacol 8(2):128\u2013137. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8020871","journal-title":"Fundam Clin Pharmacol"},{"issue":"4","key":"372_CR71","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1476-5381.2011.01286.x","volume":"163","author":"JC Schwartz","year":"2011","unstructured":"Schwartz JC (2011) The histamine H3 receptor: from discovery to clinical trials with pitolisant. Br J Pharmacol 163(4):713\u2013721. https:\/\/doi.org\/10.1111\/j.1476-5381.2011.01286.x","journal-title":"Br J Pharmacol"},{"key":"372_CR72","doi-asserted-by":"publisher","unstructured":"Setnik B, McDonnell M, Mills C, Scart-Gres C, Robert P, Dayno JM, Schwartz JC (2020) Evaluation of the abuse potential of pitolisant, a selective H3-receptor antagonist\/inverse agonist, for the treatment of adult patients with narcolepsy with or without cataplexy. Sleep 43(4). https:\/\/doi.org\/10.1093\/sleep\/zsz252","DOI":"10.1093\/sleep\/zsz252"},{"issue":"6","key":"372_CR73","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/S0301-0082(98)00060-4","volume":"56","author":"TM Tzschentke","year":"1998","unstructured":"Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol 56(6):613\u2013672. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9871940","journal-title":"Prog Neurobiol"},{"issue":"3","key":"372_CR74","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1111\/bph.12149","volume":"169","author":"M Uguen","year":"2013","unstructured":"Uguen M, Perrin D, Belliard S, Ligneau X, Beardsley PM, Lecomte JM, Schwartz JC (2013) Preclinical evaluation of the abuse potential of pitolisant, a histamine H(3) receptor inverse agonist\/antagonist compared with Modafinil. Br J Pharmacol 169(3):632\u2013644. https:\/\/doi.org\/10.1111\/bph.12149","journal-title":"Br J Pharmacol"},{"issue":"1","key":"372_CR75","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/bph.12170","volume":"170","author":"J Vanhanen","year":"2013","unstructured":"Vanhanen J, Nuutinen S, Lintunen M, Maki T, Ramo J, Karlstedt K, Panula P (2013) Histamine is required for H(3) receptor-mediated alcohol reward inhibition, but not for alcohol consumption or stimulation. Br J Pharmacol 170(1):177\u2013187. https:\/\/doi.org\/10.1111\/bph.12170","journal-title":"Br J Pharmacol"},{"key":"372_CR76","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.phrs.2021.105522","volume":"105","author":"J Wang","year":"2021","unstructured":"Wang J, Li X, Yang S, Wang T, Xu Z, Xu J, Gao H, Chen G (2021) Pitolisant versus placebo for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea: a meta-analysis from randomized controlled trials. Pharmacol Res 105:522. https:\/\/doi.org\/10.1016\/j.phrs.2021.105522","journal-title":"Pharmacol Res"},{"issue":"4","key":"372_CR77","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00413156","volume":"6","author":"JR Weeks","year":"1964","unstructured":"Weeks JR, Collins RJ (1964) Factors affecting voluntary morphine intake in self-maintained addicted rats. Psychopharmacologia 6(4):267\u2013279. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=5890552","journal-title":"Psychopharmacologia"},{"issue":"2","key":"372_CR78","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/0006-8993(78)90253-6","volume":"152","author":"RA Wise","year":"1978","unstructured":"Wise RA (1978) Catecholamine theories of reward: a critical review. Brain Res 152(2):215\u2013247. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=354753","journal-title":"Brain Res"},{"issue":"4","key":"372_CR79","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1037\/0033-295X.94.4.469","volume":"94","author":"RA Wise","year":"1987","unstructured":"Wise RA, Bozarth MA (1987) A psychomotor stimulant theory of addiction. Psychol Rev 94(4):469\u2013492. Retrieved from http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3317472","journal-title":"Psychol Rev"},{"issue":"17","key":"372_CR80","doi-asserted-by":"publisher","first-page":"5423","DOI":"10.1021\/jm8003625","volume":"51","author":"C Zhao","year":"2008","unstructured":"Zhao C, Sun M, Bennani YL, Gopalakrishnan SM, Witte DG, Miller TR, Krueger KM, Browman KE, Thiffault C, Wetter J, Marsh KC, Hancock AA, Esbenshade TA, Cowart MD (2008) The alkaloid conessine and analogues as potent histamine H3 receptor antagonists. J Med Chem 51(17):5423\u20135430. https:\/\/doi.org\/10.1021\/jm8003625","journal-title":"J Med Chem"}],"container-title":["Current Topics in Behavioral Neurosciences","The Functional Roles of Histamine Receptors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2022_372","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,28]],"date-time":"2022-09-28T20:18:24Z","timestamp":1664396304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2022_372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9783031169960","9783031169977"],"references-count":80,"URL":"https:\/\/doi.org\/10.1007\/7854_2022_372","relation":{},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"16 June 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}